{"DataElement":{"publicId":"6475021","version":"1","preferredName":"BCR-ABL1 Fusion Protein Expression Molecular Genetic Technique Or Cytogenetic Analysis Detection Status Lab Percentage Value","preferredDefinition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia. This rearrangement results in the formation of the BCR-ABL1 fusion protein._The methods and tools used for DNA analysis and manipulation._Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._The activity of perceiving, discerning, discovering or identifying._A condition or state at a particular time._the value as a percentage of 100.","longName":"BCR_ABL1_LVL","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3230401","version":"1","preferredName":"BCR-ABL1 Fusion Protein Expression Molecular Genetic Technique Or Cytogenetic Analysis Detection Status","preferredDefinition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia. This rearrangement results in the formation of the BCR-ABL1 fusion protein._The methods and tools used for DNA analysis and manipulation._Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._The activity of perceiving, discerning, discovering or identifying._A condition or state at a particular time.","longName":"3230399v1.0:3229391v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3230399","version":"1","preferredName":"BCR-ABL1 Fusion Protein Expression","preferredDefinition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia. This rearrangement results in the formation of the BCR-ABL1 fusion protein.","longName":"C36715","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR-ABL1 Fusion Protein Expression","conceptCode":"C36715","definition":"Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic leukemia.  This rearrangement results in the formation of the BCR-ABL1 fusion protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C21717-CC92-104E-E040-BB89AD4379EB","latestVersionIndicator":"Yes","beginDate":"2011-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-25","modifiedBy":"ONEDATA","dateModified":"2011-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3229391","version":"1","preferredName":"Molecular Genetic Technique Or Cytogenetic Analysis Detection Status","preferredDefinition":"The methods and tools used for DNA analysis and manipulation.:Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:The activity of perceiving, discerning, discovering or identifying.:A condition or state at a particular time.","longName":"3229391v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Genetic Technique","conceptCode":"C19235","definition":"The methods and tools used for DNA analysis and manipulation.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A173F4F0-F1D8-CE64-E040-BB89AD4371D2","latestVersionIndicator":"Yes","beginDate":"2011-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-21","modifiedBy":"ONEDATA","dateModified":"2011-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C21717-CC9F-104E-E040-BB89AD4379EB","latestVersionIndicator":"Yes","beginDate":"2011-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180234","version":"1.1","preferredName":"Lab Percentage Value","preferredDefinition":"the value as a percentage of 100.","longName":"LAB_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2954D9F1-B403-0D97-E050-BB89AD435FCC","latestVersionIndicator":"Yes","beginDate":"2004-01-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-01-14","modifiedBy":"REEVESD","dateModified":"2016-11-23","changeDescription":"v1.1 of VD replaces v1.0 to increase overall field length and include 2 decimal places. 1.14.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"BCR-ABL1 level:","type":"Preferred Question Text","description":"BCR-ABL1 level:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77D07AC8-DEA5-2535-E053-F662850ADB24","latestVersionIndicator":"Yes","beginDate":"2018-10-09","endDate":null,"createdBy":"LEEW","dateCreated":"2018-10-09","modifiedBy":"LEEW","dateModified":"2018-11-05","changeDescription":"AAML18P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}